Karin Walker
Directeur/Membre du Conseil chez CYCLACEL PHARMACEUTICALS, INC.
Profil
Karin L.
Walker is an Independent Non-Executive Director at Cyclacel Pharmaceuticals, Inc. since 2020.
She is also the Chief Accounting Officer at Prothena Corp.
Plc since 2013.
Previously, she served as an Independent Director at LifeSci Acquisition Corp.
in 2020.
From 2006 to 2009, she was the Vice President-Finance & Controller at CV Therapeutics, Inc. She then held the same position at Amyris, Inc. from 2009 to 2012.
In 2012, she became the Chief Accounting Officer & Vice President-Finance at Affymax, Inc. Before her corporate roles, she worked as an Accountant at Ernst & Young US LLP.
Ms. Walker obtained her undergraduate degree from California Polytechnic State University (San Luis Obispo).
Postes actifs de Karin Walker
| Sociétés | Poste | Début |
|---|---|---|
| PROTHENA CORPORATION PLC | Comptroller/Controller/Auditor | 20/05/2013 |
| CYCLACEL PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/11/2020 |
Anciens postes connus de Karin Walker
| Sociétés | Poste | Fin |
|---|---|---|
| VINCERX PHARMA, INC. | Directeur/Membre du Conseil | 23/12/2020 |
| AFFYMAX, INC. | Comptroller/Controller/Auditor | 01/05/2013 |
| AMYRIS, INC. | Comptroller/Controller/Auditor | 01/01/2012 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Comptroller/Controller/Auditor | 01/01/2009 |
Ernst & Young US LLP
 Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Corporate Officer/Principal | - |
Formation de Karin Walker
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| AMYRIS, INC. | Process Industries |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
Ernst & Young US LLP
Ernst & Young US LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young US LLP was engaged in providing accounting services. The company was headquartered in Pittsburgh, PA. | Commercial Services |
